as of 11-11-2026 2:05pm EST
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.
| Founded: | 1982 | Country: | United States |
| Employees: | N/A | City: | CLEARWATER |
| Market Cap: | 107.4M | IPO Year: | 1995 |
| Target Price: | $6.50 | AVG Volume (30 days): | 142.0K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.41 | EPS Growth: | 19.40 |
| 52 Week Low/High: | $2.25 - $5.08 | Next Earning Date: | 11-05-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 12.42% | Revenue Growth (next year): | 11.05% |
| P/E Ratio: | -7.16 | Index: | N/A |
| Free Cash Flow: | -9115000.0 | FCF Growth: | N/A |
SEC 8-K filings with transcript text
Nov 5, 2026 · 100% conf.
1D
+8.62%
$3.31
Act: -3.93%
5D
+20.40%
$3.67
20D
+22.00%
$3.72
2 ex_1009950.htm
ex_1009950.htm
Apyx Medical Corporation Reports Third Quarter 2026 Financial Results
• Reported total revenue of $14.0 million in the third quarter of 2026 primarily driven by 17% growth in the Surgical Aesthetics segment
• Initiated successful full commercial launch of the power liposuction handpiece for the AYON system in the third quarter
• Reaffirmed total revenue guidance for FY2026 of $59.0 million to $60.0 million
• Management to host a conference call today at 8:00 a.m. ET
CLEARWATER, FL — November 5, 2026 - Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today reported financial results for its third quarter ended September 30, 2026.
Recent Financial and Operating Highlights:
•
Reported total revenue of $14.0 million in the third quarter of 2026, compared with $12.9 million in the same period last year.
◦
Surgical Aesthetics revenue increased to $13.0 million in the third quarter of 2026, compared with $11.1 million in the third quarter of 2025, which was the result of sales of AYON domestically and Renuvion generators internationally.
◦ OEM revenue was approximately $1.1 million in the third quarter of 2026, representing a decrease of 42% from the same period last year.
• Net loss attributable to stockholders of $1.8 million in the third quarter of 2026, compared with a net loss attributable to stockholders of $2.0 million in the third quarter of 2025.
• Adjusted EBITDA was $0.4 million for the third quarter of 2026, compared with Adjusted EBITDA loss of $0.1 million for the third quarter of 2025.
• Initiated the full commercial launch of the reusable power liposuction handpiece for the AYON Body Contouring System in the third quarter of 2026, following positive feedback from key early adopter surgeons.
• Published prospective clinical study supporting Renuvion’s effects on biological markers associated with skin quality in the peer-reviewed academic journal Plastic and Reconstructive Surgery—Global Open. Among six participants completing six-month follow-up, treated tissue demonstrated 30% greater elastin fiber density and 34% less inflammation compared with untreated control areas.
“We are pleased to report 17% growth in our Surgical Aesthetics business for the quarter, reflecting continued adoption of AYON and the progress we are making in executing our commercial strategy,” said Charlie Goodwin, President and Chief Executive Officer. “Over the past year, we have continued to demonstrate the value AYON offers by providing a full suite of complementary body contouring capabilities in one integrated platform. We are building on that foundation with the broader commercial launch of power liposuction, which has received very positive early feedback from surgeons since it received FDA clearance earlier this year. We estimate that approximately 70% of plastic surgeons use power liposuction, making this an important addition that broadens AYON’s appeal.”
1
The following tables present revenue by reportable segment and geography:
Three Months Ended
Nine Months Ended
September 30,
September 30,
(In thousands)
2026
2025
$ Change
% Change
2026
2025
$ Change
% Change
Surgical Aesthetics
$ 12,970
$ 11,065
$ 1,905
17.2 %
$ 36,090
$ 28,622
$ 7,468
26.1 %
OEM
1,060
1,812
(752 )
(41.5 )%
4,314
5,058
(744 )
(14.7 )%
Total
$ 14,030
$ 12,877
$ 1,153
9.0 %
$ 40,404
$ 33,680
$ 6,724
20.0 %
Three Months Ended
Nine Months Ended
September 30,
September 30,
(In thousands)
2026
2025
$ Change
% Change
2026
2025
$ Change
% Change
Domestic
$ 9,703
$ 9,332
$ 371
4.0 %
$ 27,223
$ 23,851
$ 3,372
14.1 %
International
4,327
3,545
782
22.1 %
13,181
9,829
3,352
34.1 %
Total
$ 14,030
$ 12,877
$ 1,153
9.0 %
$ 40,404
$ 33,680
$ 6,724
20.0 %
Third Quarter 2026 Results:
Total revenue for the three months ended September 30, 2026, increased 9% to $14.0 million, compared with $12.9 million in the prior year period. Surgical Aesthetics segment sales increased 17%, or $1.9 million, to approximately $13.0 million for the three months ended September 30, 2026, when compared with $11.1 million for the three months ended September 30, 2025. The Surgical Aesthetics sales increase was driven by sales of AYON, which commenced with the commercial launch in the third quarter of 2025 and increased sales of generators internationally. These increases were partially offset by decreases in domestic sales of standalone generators and single-use handpieces globally. OEM segment sales decreased 42%, or $0.8 million, to approximately $1.1 million for the three months ended September 30, 2026 when compared with $1.8 million for the three months ended September 30, 2025. The decrease in OEM sales was due to a decrease in sales volume to existing customers. With the in
Aug 6, 2026 · 100% conf.
1D
+8.75%
$4.52
Act: -2.64%
5D
+20.51%
$5.01
20D
+22.10%
$5.08
SEC.gov | Request Rate Threshold Exceeded
U.S. Securities and Exchange Commission
You’ve Exceeded the SEC’s Traffic Limit
Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes.
Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains available to all users, we reserve the right to block IP addresses that submit excessive requests.
The block will be lifted automatically by waiting 10 minutes. Continuing to exceed the SEC’s maximum allowable request rate during the time-out period will extend the duration of the time-out period. To ensure fair access for all users, please reduce the rate of your requests and visit SEC.gov again after the 10 minute time-out period has passed.
For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact opendata@sec.gov.
For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.
Reference ID: 0.c706d217.1786199851.ff0887e0
More Information
Internet Security Policy
By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.
Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. §§ 1001 and 1030).
To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. We reserve the right to block IP addresses that submit excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests.
If a user or application submits more than 10 requests per second, further requests from the IP address(es) may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website.
Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users.
Note: We do not offer technical support for developing or debugging scripted downloading processes.
May 7, 2026 · 100% conf.
1D
+9.16%
$3.89
Act: +4.21%
5D
+20.33%
$4.28
Act: +22.47%
20D
+21.79%
$4.34
Act: +25.56%
SEC.gov | Request Rate Threshold Exceeded
U.S. Securities and Exchange Commission
You’ve Exceeded the SEC’s Traffic Limit
Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes.
Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains available to all users, we reserve the right to block IP addresses that submit excessive requests.
The block will be lifted automatically by waiting 10 minutes. Continuing to exceed the SEC’s maximum allowable request rate during the time-out period will extend the duration of the time-out period. To ensure fair access for all users, please reduce the rate of your requests and visit SEC.gov again after the 10 minute time-out period has passed.
For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact opendata@sec.gov.
For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.
Reference ID: 0.c706d217.1784334024.cccd76c2
More Information
Internet Security Policy
By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.
Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. §§ 1001 and 1030).
To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. We reserve the right to block IP addresses that submit excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests.
If a user or application submits more than 10 requests per second, further requests from the IP address(es) may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website.
Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users.
Note: We do not offer technical support for developing or debugging scripted downloading processes.
See how APYX stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "APYX Apyx Medical Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.